After a major regulatory breakthrough, Capricor Therapeutics, Inc. (NASDAQ: CAPR) stock value has significantly increased. CAPR shares have increased 10.46% to $15.10 as of the
Due to a recent licensing decision, Capricor Therapeutics, Inc.’s (NASDAQ: CAPR) stock value has been dramatically on the US stock charts today. As of the
The stock of Capricor Therapeutics, Inc. (NASDAQ: CAPR) is rising significantly on the charts right now. Following the company’s announcement of plans to submit a
Capricor Therapeutics, Inc. (CAPR) is a biopharmaceutical company engaged in the development of therapeutics for treating an array of diseases. The company’s pipeline product candidate
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.